The present invention relates to a method of treatment of hyperandrogenism in women with paroxetine and myo-inositol. In women, hyperandrogenism is a hormonal imbalance caused by excess of testosterone and/or reduced estrogen receptor sensitivity. A quantity of paroxetine, and a quantity of myo-insitol are heterogeneously combined together into a medicinal mixture. The medicinal mixture is administered to the patient in order to reduce free testosterone and increase estrogen receptor sensitivity to alleviate symptoms associated with hyperandrogenism without the side effects associated with currently available treatments.
